9 Ways Menopause Affects Women Living With Multiple Sclerosis
What strikes me most about this intersection is how invisible it has been for so long — women reporting worsening fatigue or more frequent relapses in their late 40s and being told it was 'just their MS.' The possibility that hormonal change was actively driving neurological change simply wasn't on the radar. That needs to change, and women living with MS deserve to walk into every appointment knowing this conversation is worth having.
Learn more about Rose →Estrogen Loss Removes a Key Layer of Neuroprotection
Estrogen — particularly estradiol — promotes myelin repair, reduces neuroinflammation, and supports the survival of oligodendrocytes, the cells responsible for maintaining the myelin sheath damaged in MS. When estrogen levels drop at menopause, this protective signalling diminishes, leaving the central nervous system more vulnerable to the ongoing inflammatory processes of MS. Research in animal models and early human studies suggests this is not a passive loss but an active shift in disease biology.
Lesion Burden May Increase After Menopause
Several observational studies have found that women with MS show accelerated brain atrophy and increased MRI lesion accumulation in the postmenopausal years compared to their premenopausal disease course. This pattern mirrors what is seen in progressive MS, leading researchers to investigate whether menopause acts as an independent driver of disease progression rather than simply coinciding with it. The timing is not incidental — estrogen withdrawal appears to lower the threshold at which inflammatory damage becomes structural.
Fatigue Becomes Dramatically More Complex to Manage
MS-related fatigue is already among the most disabling and least understood symptoms of the condition, and menopause adds at least three compounding layers: disrupted sleep from night sweats, anaemia risk from erratic perimenopausal bleeding, and the direct neurological fatigue that worsens when estrogen-mediated mitochondrial support declines. Women and their care teams may struggle to determine which component is driving the exhaustion on any given day, making both treatment and self-management significantly harder. Untangling these threads requires tracking symptoms alongside menstrual patterns and MRI findings rather than attributing everything to one cause.
Hot Flashes Can Trigger Temporary MS Symptom Worsening
This phenomenon has a name: Uhthoff's phenomenon, the well-documented tendency for MS symptoms to worsen temporarily when core body temperature rises. Hot flashes raise core temperature rapidly and repeatedly — sometimes dozens of times a day — meaning women with MS may experience transient visual disturbance, weakness, or cognitive slowing with every flash. This is not a true relapse but is functionally indistinguishable from one in the moment, creating significant distress and clinical ambiguity.
Brain Fog From Both Conditions Stacks in Ways That Are Hard to Attribute
Cognitive symptoms — word-finding difficulties, slowed processing, working memory gaps — appear in MS as a result of white matter lesions, and they appear in menopause as a result of estrogen withdrawal's effect on hippocampal and prefrontal function. When both are present simultaneously, the combined cognitive load can be substantially worse than either alone, and neither a neurologist nor a gynaecologist may feel equipped to address the full picture. Women are often left to advocate loudly for cognitive assessment that takes both conditions seriously at once.
Distinguishing a True MS Relapse From Menopause Symptoms Is Genuinely Difficult
A classic MS relapse involves new or worsening neurological symptoms lasting more than 24 hours, not explained by fever or another cause — but menopause provides multiple plausible alternative explanations for exactly these symptoms. Sleep deprivation from night sweats can produce cognitive and physical symptoms that mimic relapse, as can the temperature-related pseudo-exacerbations triggered by hot flashes. Neurologists are increasingly aware that menopause must be factored into relapse assessment for women in their 40s and 50s, but this is not yet standard practice everywhere.
Bladder Symptoms From Both Conditions Overlap Almost Entirely
Urinary urgency, frequency, incontinence, and recurrent urinary tract infections are hallmark MS symptoms caused by neurogenic bladder dysfunction, and they are also extremely common in menopause due to genitourinary syndrome — the thinning and drying of urogenital tissues driven by estrogen loss. A woman experiencing new or worsening bladder symptoms during perimenopause may be having a relapse, a hormonal shift, a UTI, or all three simultaneously. Thorough assessment rather than assumption is essential, because the treatment for each pathway differs significantly.
Hormone Replacement Therapy May Offer Neurological Benefit — But the Evidence Is Still Developing
Small studies and mechanistic evidence suggest that HRT, particularly estradiol-based therapy, may slow lesion accumulation and support cognitive function in women with MS going through menopause, mirroring estrogen's known neuroprotective role. MS has historically been listed as a relative contraindication to HRT due to theoretical concerns about immune modulation, but this view is being actively revisited as the risk-benefit picture becomes clearer. Women with MS considering HRT should have a detailed conversation with both their neurologist and a menopause specialist, because the decision is genuinely individual and the evidence does not yet support a one-size-fits-all answer.
Mood Changes From Menopause Can Complicate MS Psychological Health
Depression and anxiety are already significantly more prevalent in people with MS than in the general population, driven by a combination of neuroinflammatory mechanisms, lesion location, and the psychological burden of chronic illness. Perimenopause independently elevates depression risk, particularly in women with a prior history of mood sensitivity — and many women with MS qualify. The result is that psychological symptoms during this transition period are frequently undertreated because clinicians are uncertain whether to approach them as a neurological, hormonal, or psychiatric problem, when in reality all three lenses may be needed at once.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.